Multi-Electrode Catheter for Renal Neuromodulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pharmacologic strategies for managing excessive renal sympathetic nerve activity, which contributes to hypertension and renal disease, have limitations such as limited efficacy, compliance issues, and side effects.
Innovation Solution
The development of a multi-electrode radio frequency (RF) ablation catheter apparatus for intravascular renal neuromodulation, which delivers energy to the renal arteries using a catheter with a multi-electrode array that can be deployed in a helical shape within the renal artery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If pharmacologic strategies are used to manage renal sympathetic nerve activity, then treatment can be administered orally, but efficacy is limited and side effects occur
Solution Approach 1:
The patent replaces pharmacologic (chemical) mechanisms with a mechanical/electrical intervention system. A catheter with electrodes is inserted into the renal artery to deliver electrical energy directly to the renal sympathetic nerves, substituting the chemical action of oral medications with direct electrical neuromodulation, thereby improving efficacy while eliminating the need for oral administration
Solution Approach 2:
The patent introduces an intermediary delivery system (catheter with electrodes) that serves as a mediator between the external control system and the renal sympathetic nerves. This intermediary allows precise, localized delivery of electrical energy to the nerves, improving treatment reliability compared to systemic pharmacologic approaches
2Adaptability or versatility
If pharmacologic strategies are used to manage renal sympathetic nerve activity, then treatment can be administered systemically, but compliance issues arise
Solution Approach 1:
The patent substitutes the systemic pharmacologic approach with a localized mechanical/electrical intervention. The catheter delivers electrical energy directly to the renal sympathetic nerves through the renal artery, providing targeted treatment that eliminates the need for systemic medication compliance while maintaining effective coverage of the renal sympathetic nervous system
3Adaptability or versatility
If pharmacologic strategies are used to manage renal sympathetic nerve activity, then multiple drug classes can be tried, but side effects accumulate
Solution Approach 1:
The patent extracts the treatment mechanism from the pharmacologic system and places it in the electrical/neural system. By using a catheter with electrodes to deliver electrical energy directly to the renal sympathetic nerves, the approach eliminates dependence on multiple drug classes and their associated side effects, while maintaining the ability to treat renal sympathetic nerve activity through a different physiological mechanism
Solution Approach 2:
The patent replaces the chemical/pharmacologic system with an electrical/neural system. The catheter-based electrical neuromodulation provides a non-pharmacologic treatment option that avoids the side effects of multiple drug classes while maintaining effectiveness in managing renal sympathetic nerve activity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively reduces renal sympathetic nerve activity, offering a potential alternative treatment for hypertension and renal disease by modulating renal nerves electrically and thermally.
Implementation Method 1
multi-electrode radio frequency (RF) ablation catheter apparatus for intravascular renal neuromodulation, which delivers energy to the renal arteries
Implementation Method 2
multi-electrode radio frequency (RF) ablation catheter apparatus for intravascular renal neuromodulation
Data Source
AI summary
Catheter apparatuses, systems, and methods for achieving renal neuromodulation by intravascular access are disclosed herein. One aspect of the present technology, for example, is directed to a treatment device having a multi-electrode array configured to be delivered to a renal blood vessel. The array is selectively transformable between a delivery or low-profile state (e.g., a generally straight shape) and a deployed state (e.g., a radially expanded, generally helical shape). The multi-electrode array is sized and shaped so that the electrodes or energy delivery elements contact an interior wall of the renal blood vessel when the array is in the deployed (e.g., helical) state. The electrodes or energy delivery elements are configured for direct and/or indirect application of thermal and/or electrical energy to heat or otherwise electrically modulate neural fibers that contribute to renal function or of vascular structures that feed or perfuse the neural fibers.


